Page last updated: 2024-10-21

acebutolol and Heart Disease, Ischemic

acebutolol has been researched along with Heart Disease, Ischemic in 2 studies

Acebutolol: A cardioselective beta-1 adrenergic antagonist with little effect on the bronchial receptors. The drug has stabilizing and quinidine-like effects on cardiac rhythm, as well as weak inherent sympathomimetic action.
acebutolol : An ether that is the 2-acetyl-4-(butanoylamino)phenyl ether of the primary hydroxy group of 3-(propan-2-ylamino)propane-1,2-diol.

Research Excerpts

ExcerptRelevanceReference
"To examine the effect of acebutolol, a beta-adrenergic-receptor blocker, on severe regional myocardial ischemia, specifically the effects on regional myocardial function and metabolism."3.71Beta-adrenergic blockade during severe ischemia. ( Coetzee, A; Coetzee, G, 2002)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
London, MJ1
Coetzee, A1
Coetzee, G1

Other Studies

2 other studies available for acebutolol and Heart Disease, Ischemic

ArticleYear
Beta-adrenergic-receptor blockade and myocardial ischemia: something old, something new.
    Journal of cardiothoracic and vascular anesthesia, 2002, Volume: 16, Issue:6

    Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Coronary Circulation; Humans; Myocardial Ischemia;

2002
Beta-adrenergic blockade during severe ischemia.
    Journal of cardiothoracic and vascular anesthesia, 2002, Volume: 16, Issue:6

    Topics: Acebutolol; Adrenergic beta-Antagonists; Animals; Coronary Circulation; Hemodynamics; Lactic Acid; M

2002